Full Press Release Details
City, Utah - The trial of the lawsuit filed in August 2004 on behalf of the
Food and Drug Administration (FDA) alleging Quality System Regulation (QSR)
violations by Utah Medical Products, Inc. (Nasdaq: UTMD) is scheduled to
on September 26, 2005 in the U.S. District Court in Salt Lake City, Judge
S. Jenkins presiding.
will focus on UTMD's compliance with the QSR. On September 19, 2005, lawyers for
UTMD will file a pretrial brief and proposed findings of fact and conclusions
law for the Court to consider. The Company will provide a copy of UTMD's
pretrial brief and proposed findings of fact and conclusions of law to investors
who request it by calling Paul Richins at (800) 533-4984 or (801)
administrative claim for damages concerning alleged FDA misconduct was submitted
to the Department of Health and Human Services in July. The FDA has until
January 8, 2006 to consider UTMD's claim for damages. Accordingly, UTMD's
damages claim will not be addressed at the currently scheduled
Medical Products, Inc., with particular interest in health care for women
their babies, develops, manufactures, assembles and markets a broad range
well-established, safe and effective, disposable and reusable specialty medical